QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock ConferenceBusiness Wire • 05/23/23
QuidelOrtho (QDEL) Soars 5.0%: Is Further Upside Left in the Stock?Zacks Investment Research • 04/17/23
QuidelOrtho Announces the Formation of the International QuidelOrtho Women's Leadership Network (QWLN)Business Wire • 03/28/23
QuidelOrtho's (QDEL) Rapid Antigen Test Gets De Novo FDA ApprovalZacks Investment Research • 03/13/23
QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIABusiness Wire • 03/08/23
QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor ConferenceBusiness Wire • 03/02/23
ImageMover and QuidelOrtho Partner to Simplify Test-to-Treat Process for PharmaciesPRNewsWire • 02/27/23
QuidelOrtho Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022Business Wire • 01/06/23